Additionally, SAHA suppresses the activity of regulatory T cells (Treg) by targeting the c-Myc/CCL1 signaling pathway in glioma stem cells, thereby enhancing the efficacy of PD-L1 blockade therapy611 (Fig. 6). The gene discussed is CD274; the disease is glioma.